ITOC · iTonic Holdings Ltd
$0.31
0.00 (-0.84%)
At close · Aug 20
Market Cap
$7.30M
Shares
24.72M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$523.03K
+16.7%
FY2025
Net Income
-$5.1M
-671.7%
FY2025
Gross Margin
62.59%
-22.4pp
FY2025
Operating Margin
-991.71%
-819.8pp
FY2025
Diluted EPS
-$0.32
-511.5%
FY2025
Operating Cash Flow
-$3.23M
-317%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| $523.03K | $448.2K | $628.59K | $679.78K | |
| $195.68K | $67.04K | $157.76K | $121.63K | |
| $327.35K | $381.16K | $470.83K | $558.15K | |
| 62.59% | 85.04% | 74.9% | 82.11% | |
| $459.14K | $93.32K | $84.47K | $73.72K | |
| $181.85K | $307.53K | $268.14K | $294.86K | |
| $4.87M | $750.56K | $424.9K | $162.06K | |
| — | $59.72K | $57.8K | $54.08K | |
| $5.51M | $1.15M | $777.51K | $530.63K | |
| -$5.19M | -$770.27K | -$306.68K | $27.52K | |
| -991.71% | -171.86% | -48.79% | 4.05% | |
| $88.58K | $131.51K | $46.17K | $43.51K | |
| -$5.1M | -$638.76K | -$260.51K | $71.03K | |
| — | $21.83K | -$19.29K | -$12.95K | |
| -$5.1M | -$660.59K | -$241.22K | $83.98K | |
| -974.68% | -147.39% | -38.37% | 12.35% | |
| -$483 | — | — | — | |
| -$5.1M | -$665.7K | -$251.18K | $424 | |
| USD/shares | -$0.32 | -$0.05 | -$0.02 | $0.01 |
| USD/shares | -$0.32 | -$0.05 | -$0.02 | $0.01 |
| shares | 16.04M | 12.72M | 12M | 12M |
| shares | 16.04M | 12.72M | 12M | 12M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2025: $407.35K in dividends.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Sales of FTTPS | $362,850 | $369,550 | $609,348 | — |
| Sales of Medical Auxiliary Supplies | $160,181 | $78,646 | $19,243 | — |
| Contract Liabilities | $31,637 | $28,668 | $132,656 | — |
| Contract Liabilities | — | $28,668 | $132,656 | — |
| Sales of FTTPS | — | $369,550 | $609,348 | $668,680 |
| Sales of Medical Auxiliary Supplies | — | $78,646 | $19,243 | $11,097 |
Key facts
CIK
1970544
CUSIP
G71399102
13F (30d)
12 filings
12 filers